| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/18/2004 | CA2496834A1 Method of treatment of asthma using antibodies to complement component c5 |
| 03/18/2004 | CA2496566A1 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | CA2495480A1 Interferon and immunoglobulin fc fragment hybrid |
| 03/18/2004 | CA2441469A1 Methods and compositions for treating alzheimer's disease |
| 03/17/2004 | EP1398326A2 Monoclonal antibodies against recombinant stratum corneum chymotryptic enzyme (SCCE) |
| 03/17/2004 | EP1398325A1 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/17/2004 | EP1397494A2 Fungal gene cluster associated with pathogenesis |
| 03/17/2004 | EP1397488A1 Novel compounds for chemiluminescense procedures |
| 03/17/2004 | EP1397486A2 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 03/17/2004 | EP1397387A1 Antibodies specific for cd44v6 |
| 03/17/2004 | EP1397386A2 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same |
| 03/17/2004 | EP1397383A2 Secreted polypeptide and their use in the treatment of bone disorders |
| 03/17/2004 | EP1397159A2 Stable liquid formulations of antibodies |
| 03/17/2004 | EP1397158A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS |
| 03/17/2004 | EP1397151A2 Wnv core protein/capsid interacting protein and uses of the same |
| 03/17/2004 | EP1259249A4 Method for detecting the presence of target bacteria or a target component carbohydrate antigen thereof |
| 03/17/2004 | EP0970107B1 Cyclosporine derivatives and uses thereof |
| 03/17/2004 | EP0915974B1 Modified tie-2-receptor ligands |
| 03/17/2004 | EP0866655B1 Murine model for human carcinoma |
| 03/17/2004 | EP0762881B1 Use of active agents for the manufacture of medicaments for the treatment of rheumatoid arthritis |
| 03/17/2004 | CN1483041A GLP-1 fusion protein |
| 03/17/2004 | CN1482861A Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk by filtration to remove bacteria |
| 03/17/2004 | CN1482258A DNA antibody and uses thereof |
| 03/17/2004 | CN1482244A Specific gene NASG coding protein for man nasopharynx tissue and preparation of antibody |
| 03/17/2004 | CN1482141A Method for preparing specific composite IgY against periodontal disease and group system thereof |
| 03/17/2004 | CN1482140A Process for extracting medicinal protein from ostrich blood and use thereof |
| 03/17/2004 | CN1142183C Anti-idiotype microantibody and its preparing process and application |
| 03/17/2004 | CN1142177C Isolated MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 03/16/2004 | US6706872 Polynucleotides encoding Plasmodium vivax blood stage antigens |
| 03/16/2004 | US6706870 Nucleic acids encoding CTLA-8; and related reagents |
| 03/16/2004 | US6706708 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706514 Polypeptides capable of interacting with the human topoisomerase IIIα |
| 03/16/2004 | US6706509 Serine and threonine kinase activity |
| 03/16/2004 | US6706501 Isolated nucleic acid molecule comprising selected nucleic acid sequence, encoding protein having 10,12-linoleate isomerase activity |
| 03/16/2004 | US6706488 Antigenic compound for use in the treatment,and diagnosis of cancer |
| 03/16/2004 | US6706487 Monoclonal antibody specific for human interleukin-18 comprising specified light chain and heavy chain amino acid sequences |
| 03/16/2004 | US6706484 Protein/(poly)peptide libraries |
| 03/16/2004 | US6706270 Compounds |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/16/2004 | US6706265 Immunosuppressing graft rejection |
| 03/16/2004 | US6706264 Use of IL-12 antagonists in the treatment of conditions promoted by an increase in levels of IFN-y |
| 03/16/2004 | CA2234204C Novel antibody, renin-active substance containing the same and prorenin assay reagent using the same |
| 03/16/2004 | CA2136961C Bnp antibody and immunoassay using it |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004021007A1 Elisa kits for detecting collagenase 3 as a proenzyme and in an activated form in body fluids and cell culture supernatants |
| 03/11/2004 | WO2004021000A1 Immunocapture-based measurements of mammalian pyruvate dehydrogenase complex |
| 03/11/2004 | WO2004020668A2 Method for treating synovial sarcoma |
| 03/11/2004 | WO2004020665A2 Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases |
| 03/11/2004 | WO2004020658A1 Diagnosis of shwachman-diamond syndrome |
| 03/11/2004 | WO2004020633A1 Human antihuman interleukin-6 antibody and fragment of the antibody |
| 03/11/2004 | WO2004020606A2 Method of resisting osteoclast formation |
| 03/11/2004 | WO2004020597A2 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 03/11/2004 | WO2004020588A2 Transferrin fusion protein libraries |
| 03/11/2004 | WO2004020579A2 Method of humanizing immune system molecules |
| 03/11/2004 | WO2004020574A2 Scfv fragment to human cathepsin l and methods of use |
| 03/11/2004 | WO2004020456A2 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
| 03/11/2004 | WO2004020404A2 Modified transferin-antibody fusion proteins |
| 03/11/2004 | WO2004019980A1 Vaccine against yersinia comprising one or two antibodies, one specific for yersinia pestis f1-antigen and the other one for yersina pestis v-antigen |
| 03/11/2004 | WO2004019966A1 Method of stabilizing protein solution preparation |
| 03/11/2004 | WO2004019886A2 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | WO2004019883A2 Tick polypeptides as anticoagulants and vaccines |
| 03/11/2004 | WO2004019866A2 Compositions and methods for treating cardiovascular disease |
| 03/11/2004 | WO2004019861A2 Stable ph optimized formulation of a modified antibody |
| 03/11/2004 | WO2004019860A2 Formulations of modified antibodies and methods of making the same |
| 03/11/2004 | WO2003097698A8 Treatment of cancer by the use of anti fas antibody |
| 03/11/2004 | WO2003096782A3 Process for preparing maytansinol |
| 03/11/2004 | WO2003092630A3 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003078637A3 Optimizing glycan processing in plants |
| 03/11/2004 | WO2003074563A3 Means and methods for manipulating hypersensitivity-like responses |
| 03/11/2004 | WO2003068261A3 Means and methods for altering the motility of the gastrointestinal tract |
| 03/11/2004 | WO2003057838A3 Antibodies against the muc18 antigen |
| 03/11/2004 | WO2003055908A3 Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003046572A3 Biopolymer markers predictive of alzheimers disease |
| 03/11/2004 | WO2003046007A3 Treatment of micro-organism infection |
| 03/11/2004 | WO2003042374A3 Isolation of neurones and stem cells for nerve fibres from a sample |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003041736A3 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 03/11/2004 | WO2003033535A3 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 03/11/2004 | WO2003027135A3 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 03/11/2004 | WO2003018799A3 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/11/2004 | WO2003018771A3 A system for antibody expression and assembly |
| 03/11/2004 | WO2003014960A3 Method of identifying a consensus sequence for intracellular antibodies |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2003008548A3 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 03/11/2004 | WO2002083709A3 Kinases and phosphatases |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | US20040049024 Compositions and methods related to the minn1 tumor suppressor gene and protein |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048370 Cell targeting methods and compositions |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048332 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |